• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酵母、霉菌和放线菌的蛋白质及甘露聚糖多糖抗原的特性分析

Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes.

作者信息

Reiss E, Huppert M, Cherniak R

出版信息

Curr Top Med Mycol. 1985;1:172-207. doi: 10.1007/978-1-4613-9547-8_7.

DOI:10.1007/978-1-4613-9547-8_7
PMID:3916766
Abstract

Antigens in coccidioidin were compared with purified subfractions via tandem immunoelectrophoresis (IEP) and by a combination of advancing line and crossed IEP. Rocket IEP was suitable for titrating the reactions and showing the relationship between column fractions. These techniques required multicomponent antisera produced by hyperimmunization over many months and by the use of known standard migration pairs. The IEP variations were used to chart the development of antisera against coccidioidin factors, to monitor antigen purifications, and to test the immunochemical homogeneity of an isolated antigen. Mannose-based heteroglycans of Cryptococcus neoformans were recovered from the culture filtrate. After precipitation of the major viscous glucuronoxylomannan (GXM) with ethanol or cetyltrimethylammonium bromide, the supernate is reserved because it contains a galactoxylomannan (GalXM). After removal of glucuronic acid from the GXM, the resulting xylomannan of serotype A was amenable to 13C-nuclear magnetic resonance (NMR) spectrometry; it revealed nonreducing xylose, alpha-1,3-mannose, and alpha-1,2/1,3 disubstituted mannose, thus confirming by an independent means what was previously known. The characterization sequence of GalXM included: (1) gas-liquid chromatography (GLC) of neutral sugars as peracetylated aldononitriles; (2) methylation-fragmentation GLC mass spectrometry to determine the glycosidic linkages; and (3) 13C-NMR showing similarities to mannan of Saccharomyces cerevisiae. Affinity chromatography of the GalXM on concanavalin A separated the galactoxylo component from an adsorbed mannoprotein. Selection of monoclonal antibodies (MAbs) relies on presumptive enzyme immunoassays (EIAs) or radioimmunoassays for rapid screening of clones and for determination of isotypes; however, higher resolution confirmatory tests are needed to obtain MAbs of desired specificity. MAbs against Candida tropicalis mannan were labeled with horseradish peroxidase to use for detecting mannan in serum. MAbs against the partially purified "m" factor of histoplasmin were characterized by the enzyme-linked immunoelectro-transfer blot technique (EITB), revealing unsuspected complexity in the antigen. Secreted proteins of Nocardia asteroides were isoelectrically focused; three proteins, identified by EITB as promising to be specific for that actinomycete, were cut out of gels and used to immunize mice for production of MAbs. The fimbriae of Actinomyces viscosus and A. naeslundii that mediate lactose-reversible coagglutination with Streptococcus sanguis have been used to evoke MAbs.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

通过串联免疫电泳(IEP)以及前进线免疫电泳和交叉免疫电泳相结合的方法,对球孢子菌素中的抗原与纯化亚组分进行了比较。火箭免疫电泳适用于滴定反应并显示柱级分之间的关系。这些技术需要通过数月的超免疫以及使用已知的标准迁移对产生的多组分抗血清。免疫电泳变异被用于绘制针对球孢子菌素因子的抗血清的发展过程、监测抗原纯化以及测试分离抗原的免疫化学均一性。新型隐球菌的基于甘露糖的杂聚糖是从培养滤液中回收的。用乙醇或十六烷基三甲基溴化铵沉淀主要的粘性葡糖醛酸木聚糖甘露聚糖(GXM)后,保留上清液,因为其中含有半乳甘露聚糖(GalXM)。从GXM中去除葡糖醛酸后,所得的A型木聚糖甘露聚糖适合进行13C核磁共振(NMR)光谱分析;它揭示了非还原木糖、α-1,3-甘露糖和α-1,2/1,3双取代甘露糖,从而通过一种独立的方法证实了先前已知的情况。GalXM的表征序列包括:(1)将中性糖作为全乙酰化醛糖腈进行气液色谱(GLC)分析;(2)甲基化-碎片化GLC质谱分析以确定糖苷键;(3)13C-NMR显示与酿酒酵母甘露聚糖相似。GalXM在伴刀豆球蛋白A上的亲和色谱分离出了吸附的甘露糖蛋白中的半乳甘露糖组分。单克隆抗体(MAb)的筛选依赖于推测性酶免疫测定(EIA)或放射免疫测定,用于快速筛选克隆以及确定同种型;然而,需要更高分辨率的确认性试验来获得具有所需特异性的MAb。针对热带念珠菌甘露聚糖的MAb用辣根过氧化物酶标记,用于检测血清中的甘露聚糖。针对组织胞浆菌素部分纯化的“m”因子的MAb通过酶联免疫电转移印迹技术(EITB)进行表征,揭示了该抗原中未被怀疑的复杂性。星形诺卡菌的分泌蛋白进行了等电聚焦;通过EITB鉴定为有望对该放线菌具有特异性的三种蛋白质从凝胶中切出,用于免疫小鼠以产生MAb。粘性放线菌和内氏放线菌的菌毛介导与血链球菌的乳糖可逆性协同凝集,已被用于引发MAb。(摘要截短至400字)

相似文献

1
Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes.酵母、霉菌和放线菌的蛋白质及甘露聚糖多糖抗原的特性分析
Curr Top Med Mycol. 1985;1:172-207. doi: 10.1007/978-1-4613-9547-8_7.
2
Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.葡聚糖醛酸木聚糖、半乳葡聚糖和甘露蛋白在新型隐球菌荚膜中占据空间上分离且离散的区域。
Virulence. 2010 Nov-Dec;1(6):500-8. doi: 10.4161/viru.1.6.13451. Epub 2010 Nov 1.
3
An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan.一种针对半乳甘露聚糖的抗新型隐球菌单克隆抗体。
Res Immunol. 1990 Jan;141(1):33-42. doi: 10.1016/0923-2494(90)90099-k.
4
Galactoxylomannans of Cryptococcus neoformans.新型隐球菌的半乳甘露聚糖
Infect Immun. 1992 Mar;60(3):1084-8. doi: 10.1128/iai.60.3.1084-1088.1992.
5
Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.通过碳-13核磁共振光谱法测定新型隐球菌A血清型分离株中葡糖醛酸木甘露聚糖的结构变异性。
Carbohydr Res. 1992 Sep 2;233:205-18. doi: 10.1016/s0008-6215(00)90932-7.
6
Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans.新型隐球菌CAP突变体胞外多糖的产生
Eukaryot Cell. 2009 Aug;8(8):1165-73. doi: 10.1128/EC.00013-09. Epub 2009 Jun 19.
7
Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.新型隐球菌多糖成分半乳甘露聚糖的荚膜定位
Eukaryot Cell. 2009 Jan;8(1):96-103. doi: 10.1128/EC.00331-08. Epub 2008 Oct 24.
8
Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67.新型隐球菌Cap67半乳甘露聚糖的结构表征
Carbohydr Res. 1998 Jan;306(1-2):315-30. doi: 10.1016/s0008-6215(97)10058-1.
9
Reassessment of antigenic determinant of Saccharomyces cerevisiae serotype Ia.酿酒酵母Ia血清型抗原决定簇的重新评估。
Microbiol Immunol. 1990;34(10):825-40. doi: 10.1111/j.1348-0421.1990.tb01061.x.
10
Immunoelectronmicroscopic characterization of monoclonal antibodies (MAbs) against Cryptococcus neoformans.针对新型隐球菌的单克隆抗体的免疫电子显微镜特征分析
Mol Cell Probes. 1989 Dec;3(4):345-61. doi: 10.1016/0890-8508(89)90014-5.

引用本文的文献

1
Mannoprotein MP84 mediates the adhesion of Cryptococcus neoformans to epithelial lung cells.甘露糖蛋白MP84介导新型隐球菌与肺上皮细胞的黏附。
Front Cell Infect Microbiol. 2014 Aug 19;4:106. doi: 10.3389/fcimb.2014.00106. eCollection 2014.
2
UDP-glucuronic acid decarboxylases of Bacteroides fragilis and their prevalence in bacteria.脆弱拟杆菌的 UDP-葡萄糖醛酸脱羧酶及其在细菌中的普遍性。
J Bacteriol. 2011 Oct;193(19):5252-9. doi: 10.1128/JB.05337-11. Epub 2011 Jul 29.
3
Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.
葡聚糖醛酸木聚糖、半乳葡聚糖和甘露蛋白在新型隐球菌荚膜中占据空间上分离且离散的区域。
Virulence. 2010 Nov-Dec;1(6):500-8. doi: 10.4161/viru.1.6.13451. Epub 2010 Nov 1.
4
Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions.新型隐球菌来源的细胞外囊泡调节巨噬细胞功能。
Infect Immun. 2010 Apr;78(4):1601-9. doi: 10.1128/IAI.01171-09. Epub 2010 Feb 9.
5
Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans.新型隐球菌CAP突变体胞外多糖的产生
Eukaryot Cell. 2009 Aug;8(8):1165-73. doi: 10.1128/EC.00013-09. Epub 2009 Jun 19.
6
The capsule of the fungal pathogen Cryptococcus neoformans.新型隐球菌这种真菌病原体的荚膜。
Adv Appl Microbiol. 2009;68:133-216. doi: 10.1016/S0065-2164(09)01204-0.
7
Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.新型隐球菌荚膜中的径向质量密度、电荷和表位分布。
Eukaryot Cell. 2007 Jan;6(1):95-109. doi: 10.1128/EC.00306-06. Epub 2006 Nov 17.
8
A yeast under cover: the capsule of Cryptococcus neoformans.隐藏在酵母之下:新型隐球菌的荚膜
Eukaryot Cell. 2003 Aug;2(4):655-63. doi: 10.1128/EC.2.4.655-663.2003.
9
Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.一种与新型隐球菌荚膜多糖反应的小鼠单克隆抗体的制备、特性鉴定及抗体特异性
Infect Immun. 1987 Mar;55(3):742-8. doi: 10.1128/iai.55.3.742-748.1987.
10
Models of cell differentiation in conidial fungi.分生孢子真菌中的细胞分化模型。
Microbiol Rev. 1986 Jun;50(2):95-132. doi: 10.1128/mr.50.2.95-132.1986.